Mice Model Market: Impact of Technological Advancements on Research Outcomes

Comments · 78 Views

Mice Model Market By Mice Type (Inbred, Hybrid), Services (Breeding, Cryopreservation, Quarantine), Technology (CRISPR, Nuclear Transfer), Application (Oncology, Cardiology, Neuro), End User (Research, Academia, Pharmaceutical) - Global Forecast to 2030

Meticulous Research®, a global leader in market research, has released a comprehensive report titled, "Mice Model Market by Mice Type (Inbred, Hybrid), Services (Breeding, Cryopreservation, Quarantine), Technology (CRISPR, Nuclear Transfer), Application (Oncology, Cardiology, Neurology), End User (Research, Academia, Pharmaceutical) - Global Forecast to 2030."

Request pdf @ https://www.meticulousresearch.com/download-sample-report/cp_id=4151

According to this latest report, the mice model market is projected to reach $2.48 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.5% from 2023 to 2030. The market's growth is largely driven by the effectiveness of mice as models for studying human diseases, the increasing prevalence of cancer, rising research funding, and the growing demand for personalized medicine. Technological advancements in mice model development are expected to create further growth opportunities in the market.

Despite the positive outlook, the market faces challenges, including ethical concerns and regulatory restrictions, which may hinder growth to some extent. Additionally, the high costs associated with mice models and a lack of skilled personnel for animal studies pose significant challenges.

Key Players in the Mice Model Market

The mice model market is highly competitive, with key players including:

  • Charles River Laboratories International, Inc. (U.S.)
  • The Jackson Laboratory (U.S.)
  • Laboratory Corporation of America Holdings (U.S.)
  • Horizon Discovery Group plc (U.K.)
  • Trans Genic Inc. (Japan)
  • GenOway S.A. (France)
  • Taconic Biosciences, Inc. (U.S.)
  • Envigo Ltd (U.S.)
  • Janvier Labs (France)
  • Ingenious Targeting Laboratory (U.S.)
  • Harbour Antibodies B.V. (China) (a subsidiary of HBM Holdings)
  • Crescendo Biologics Ltd. (U.K.)
  • Deltagen Inc. (U.S.)
  • ImmunoGenes Kft. (Hungary)

These companies play a pivotal role in the market, focusing on innovative technologies and expanding their product offerings to cater to the growing demand.

Future Outlook for the Mice Model Market

The mice model market is segmented by various factors, including mice type, services, technology, application, end user, and geography. This segmentation helps to understand the market dynamics and identify growth opportunities in different areas.

Mice Type Segment: Inbred Mice Leading the Way

In 2023, the inbred mice segment is expected to dominate the market, holding the largest share. This is primarily due to the high demand for inbred mice, which are known for their unique genetic makeup and ability to produce consistent and reliable results in experimental studies. Inbred mice are widely used in research because they provide a controlled environment to study genetic variations and disease mechanisms, making them invaluable in scientific research.

As the mice model market continues to grow, advancements in technology and increased focus on personalized medicine are likely to drive further developments, making this a dynamic and evolving sector.

Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004s
Connect with us on LinkedIn- 
https://www.linkedin.com/company/meticulous-research
Connect with us on Twitter- 
https://twitter.com/MeticulousR123

Comments